Origin BioMed Inc.: federal grants and contributions: 13 agreements; $6.8M value; 2 departments; 3 programs.
Assay record ASY-CA-0E1AWBF1XQ · Cite as: Assay Systems, “Origin BioMed Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/origin-biomed-inc/
The Development of Novel Treatments for Neuropathic Pain
Develop a marketing program
Development and launch of enhanced product
Develop a platform around Origin BioMed products to reach consumers
Marketing to export analgesic drug (new SKU) into US market
OTC neuropathic pain products for North American & EU Market
Export marketing strategy (US)
Advertising in Canada and US to increase brand awareness
Consulting for expansion into markets in the United States
Hire marketing manager and develop expertise in e-commerce
Undertake quality assurance activities
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.